A comparison of the cost-effectiveness of remifentanil versus fentanyl as an adjuvant to general anesthesia for outpatient gynecologic surgery.

The unique pharmacokinetic properties of remifentanil make it a potentially useful adjuvant during general anesthesia for ambulatory surgery. Fentanyl, inexpensive and easy to administer, is the most common opioid used for this purpose. As an adjuvant to general anesthesia for outpatient gynecologic surgery, we questioned if remifentanil was cost-effective as an alternative to fentanyl. Thirty-four patients undergoing gynecologic laparoscopy or hysteroscopy were prospectively and randomly assigned to a standard practice (n = 18) or a study (n = 16) group. Standard practice patients received fentanyl (3 microg/kg) before induction; study patients received remifentanil by continuous infusion (0.5 microg x kg. min(-1) at induction, then 0.2 microg x kg x min(-1)). Sevoflurane was titrated to a Bispectral index value of 40-55. We investigated recovery profiles, patient and health care professional satisfaction, and drug costs. The incidence of rescue antiemetic treatment (2 of 16 vs. 8 of 18; P = 0.013) and the nausea visual analog scale scores during second stage recovery (0.2 vs. 0.6; P = 0.044) were more frequent in the study group. However, the incidence of intraoperative adverse events and other postoperative sequelae, recovery times, pain and nausea visual analog scale scores, opioid analgesic dosage requirements in the postanesthetic care unit, and satisfaction survey responses were similar between groups. Perioperative drug costs per patient were $17.72 more in the remifentanil (vs. fentanyl) group.

The use of near-infrared cerebral oximetry in awake carotid endarterectomy.

STUDY OBJECTIVE: To determine the utility of cerebral oximetry for monitoring the adequacy of cerebral blood flow (CBF) during carotid cross-clamp. DESIGN: Prospective study. SETTING: University hospital. PATIENTS: 16 consecutive ASA physical status III (or higher) patients for awake carotid endarterectomy (CEA). INTERVENTIONS: Regional cerebral oxygen saturation (SaO2) was monitored continuously during CEA, which was performed by the same surgeon, and with standard regional anesthetic, sedation, monitoring, and operative techniques. Data were recorded and analyzed using repeated measures analysis of variance (ANOVA). MEASUREMENTS AND MAIN RESULTS: 14 hemodynamically stable patients demonstrated significant decreases in cerebral SaO2 from baseline: 69 + 1.8% to 64 + 1.2% at carotid cross-clamp (p < 0.001). After 5, 10, and 15-minute cross-clamp time, cerebral SaO2 was 63 + 1.4%, 64 + 1.5%, and 63 + 1.4%, respectively (p < 0.001, vs. baseline). On cross-clamp removal, cerebral SaO2 rose significantly: 67 + 1.6% (p < 0.01 vs. 5, 10, and 15 min). Two hypotensive patients (mean arterial pressures of 40 and 43 mmHg) developed signs and symptoms of global cerebral ischemia, with a concomitant decrease in cerebral oximetry (40% and 48%, respectively). These changes resolved with correction of hypotension. CONCLUSION: Cerebral SaO2 decreased significantly on carotid cross-clamp in patients undergoing awake CEA. Hemodynamically stable patients demonstrated no evidence of regional brain failure when SaO2 decreased to 63% (mean decrease of 7.2%). Two hemodynamically unstable patients had evidence of global brain failure when SaO2 was less than 48% (mean decrease of 36%). Our findings suggest that cerebral oximetry reflects CBF, and it may be an effective, noninvasive method of monitoring regional cerebral oxygenation changes during CEA. Significant reductions in regional SaO2 may be tolerated without evidence of brain failure. Further studies are needed to define an SaO2 threshold that reflects regional brain failure.